Tuesday, November 3, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryFDA clears AMIRO LED wrinkle mask under 510(k)todayDevices & TechAllergan Aesthetics Presents HArmonyCa Data for GLP-1 Patientslast weekBusiness & M&AAbbVie director Jennifer Davis resigns to lead AligntodayRegulatoryGalderma's Relfydess Approved in China for Frown Lineslast weekMarketRevance survey: 74% say menopause raised aesthetic interestyesterdayDevices & TechKeyue's dual-wavelength laser clears FDA as predicate match6 days agoMarketBOTOX Cosmetic Day returns Nov. 18 with Allē offers3 days agoDevices & TechGalderma launches eye cream with TriHex+ peptide6 days agoRegulatoryInibio's Inibo wins China approval, third Korean toxin3 days agoBusiness & M&ABausch Health raises 2026 guidance on 14 straight quarters of growth5 days agoBusiness & M&AAbbVie's Aesthetics Revenue Slips as Botox Cosmetic Gains4 days agoBusiness & M&AEstablishment Labs posts first positive cash quarter4 days ago
Regulatory

FDA clears AMIRO LED wrinkle mask under 510(k)

Shenzhen Accompany Technology's over-the-counter light mask was found substantially equivalent to a predicate, and the FDA listing says little more.

A close-up of a laboratory desk with colorful chemicals in glassware, featuring a researcher in protective gear.
Photo: www.kaboompics.com / Pexels

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

The FDA's database entry for the AMIRO Spectra 10-in-1 LED Light Therapy Mask (L3) lists a 510(k) decision of Substantially Equivalent, dated October 19, 2026. The applicant is Shenzhen Accompany Technology Co., Ltd., based in Shenzhen, China. The file number is K262932.

The filing was received August 21, 2026, and the record was last updated November 2, 2026. That is a fast turn for a 510(k), roughly two months from receipt to decision. I would not read much into the speed by itself, but owners should know the clock is short when they plan a launch.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

The FDA decision date on the AMIRO mask is October 19, 2026, and the listing shows the decision as Substantially Equivalent.

What the listing shows

The device is classed under the name "Light Based Over The Counter Wrinkle Reduction. The regulation number is 878.4810. The product code is OHS, with a subsequent product code of OLP. The medical specialty is General & Plastic Surgery, and the panel is General & Plastic Surgery.

The review was not done by a third party. The submission is not a combination product, and it does not carry a Predetermined Change Control Plan.

The correspondent is Feiying Drug & Medical Consulting Technical Service Group, also in Shenzhen. The applicant contact is listed as Chan Fu. The correspondent contact is Axiu Yang.

What it means for practices (analysis)

This is a 510(k) for an over-the-counter wrinkle device. The classification language is the important part. A device cleared under this name is a consumer-facing product that a shopper can buy without a prescription or a clinic visit. It is not a professional treatment device that a licensed operator runs on a patient.

That matters for your business in one specific way. If the AMIRO mask is sold at retail or online, it competes for the same wrinkle-minded customer who books a facial or a light treatment in your room. It does not compete for a clinical procedure. I would price that threat as low-intensity but constant, the way at-home LED has always worked.

The other thing to watch is how the device gets described in marketing. An OTC clearance covers a stated use. Any claim that goes past that use, or any suggestion that the mask does what a clinic device does, is a labeling question, and it is not a question the FDA listing answers for you.

What owners can do

Pull the FDA entry and read the device name and classification text yourself before you repeat any claim about this product to a client. The name is in the listing, and the listing is what regulators will compare against.

If a client asks about the AMIRO mask, explain the difference between an OTC device and in-office treatment in plain language. Know which uses are on the label, and know that the 510(k) does not clear the device for any use beyond the one in its classification.

If you sell at-home devices, check the labeling you are allowed to use under the clearance before you put it into a sales script.

What we don't know yet

The FDA listing does not include the full indications for use, the device labeling, the predicate device, or the performance testing submitted with the file. Those documents may be available through FDA's public 510(k) file, but this listing does not contain them, so I cannot say what the mask is labeled to treat or what the predicate is.

I also cannot confirm the device's retail availability in the United States. The listing does not name a distributor, a launch date, or a price. Anyone who tells you the mask is on shelves is working from a source this document does not supply.

Business information, not medical or legal advice. Verify regulatory status at FDA.gov.

Source: original report ↗

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/fda-clears-amiro-led-wrinkle-mask-510k/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →